iSpecimen/$ISPC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About iSpecimen
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
- Ticker
- $ISPC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 7
- Headquarters
- Woburn, United States
- Website
- ispecimen.com
iSpecimen Metrics
BasicAdvanced
$1.8M
-
-$21.95
1.63
-
Price and volume
Market cap
$1.8M
Beta
1.63
52-week high
$6.77
52-week low
$0.64
Average daily volume
227K
Financial strength
Current ratio
0.819
Quick ratio
0.81
Long term debt to equity
0.104
Total debt to equity
0.139
Interest coverage (TTM)
-30,883.58%
Profitability
EBITDA (TTM)
-9.285
Gross margin (TTM)
-108.26%
Net profit margin (TTM)
-2,449.04%
Operating margin (TTM)
-2,020.05%
Revenue per employee (TTM)
$70,000
Management effectiveness
Return on assets (TTM)
-87.69%
Return on equity (TTM)
-968.47%
Valuation
Price to revenue (TTM)
0.792
Price to book
0.62
Price to tangible book (TTM)
-1.2
Price to free cash flow (TTM)
-0.042
Free cash flow yield (TTM)
-2,357.93%
Free cash flow per share (TTM)
-16.727
Growth
Revenue change (TTM)
-92.11%
Earnings per share change (TTM)
-91.06%
3-year revenue growth (CAGR)
-64.15%
3-year earnings per share growth (CAGR)
-72.00%
iSpecimen Financial Performance
Revenues and expenses
iSpecimen Earnings Performance
Company profitability
Upcoming events
No upcoming events
iSpecimen News
AllArticlesVideos
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
Newsfile Corp1 week ago
iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent
Newsfile Corp2 weeks ago
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
Newsfile Corp1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.